Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 020812
Company: HALEON US HOLDINGS
Company: HALEON US HOLDINGS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| INFANT'S ADVIL | IBUPROFEN | 50MG/1.25ML | SUSPENSION/DROPS;ORAL | Over-the-counter | None | Yes | Yes |
| PEDIATRIC ADVIL | IBUPROFEN | 100MG/2.5ML | SUSPENSION/DROPS;ORAL | Discontinued | None | Yes | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 07/06/2017 | SUPPL-24 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020812Orig1s024lbl.pdf | |
| 03/24/2017 | SUPPL-23 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020812Orig1s023lbl.pdf | |
| 07/24/2013 | SUPPL-19 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020812s019lbledt.pdf |
| 01/12/2000 | SUPPL-3 | Efficacy-New Patient Population | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/020812s003lbl.pdf |